Nataliya Zelisko

Dr. Nataliya Zelisko

Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NZNataliya Zelisko
Nataliya Zelisko
DADmytro Atamanyuk
Dmytro Atamanyuk
OVOlexandr Vasylenko
Olexandr Vasylenko
PGPhilippe Grellier
Philippe Grellier
Roman LesykRoman Lesyk
Roman Lesyk

1 December 2015 in Tetrahedron
Verified
Journal Article
Closed access
NZNataliya Zelisko
Nataliya Zelisko
DADmytro Atamanyuk
Dmytro Atamanyuk
YOYurii V. Ostapiuk
Yurii V. Ostapiuk
ABAndriy Bryhas
Andriy Bryhas
VMVasyl Matiychuk
Vasyl Matiychuk
Roman LesykRoman Lesyk
Roman Lesyk

1 January 2014 in Tetrahedron
Verified
Journal Article
Closed access
NZNataliya Zelisko
Nataliya Zelisko
DADmytro Atamanyuk
Dmytro Atamanyuk
OVOlexandr Vasylenko
Olexandr Vasylenko
ABAndriy Bryhas
Andriy Bryhas
VMVasyl Matiychuk
Vasyl Matiychuk
Roman LesykRoman Lesyk
Roman Lesyk

18 August 2025 in European Journal of Medicinal Chemistry Reports
Verified
Journal Article
Open access
NZNataliya Zelisko
Nataliya Zelisko
Roman LesykRoman Lesyk
Roman Lesyk

29 February 2020 in Biopolymers and Cell
Verified
Journal Article
Open access
PDF file
AKAnna P. Kryshchyshyn-Dylevych
Anna P. Kryshchyshyn-Dylevych
NZNataliya Zelisko
Nataliya Zelisko
PGP. Grellier
P. Grellier
Roman LesykRoman Lesyk
Roman Lesyk
Aim. Synthesis of a series of thiazolidinone-and pyrazoline-related compounds. In vitro screening of antiplasmodial activity of versatile heterocyclic derivatives. Methods: organic wet synthesis, analytical and spectral methods, pharmacological screening, SAR analysis. Results. A series of different thiazolidinone-and pyrazoline-based derivatives was screened against Plasmodium falciparum in in vitro assays. 5-(Z)-Arylidene-2-arylidenehydrazono-3-(4-hydroxyphenyl)-4-thiazolidinones showed high growth inhibition rates with the IC 50-2.32-2.39 µM. 5-Bromo-1-[2-[3-(4-chlorophenyl)-5-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl]indoline-2,3-dione 3 was the most active compound among tested with the IC 50-1.81 µM. Based on the screening data some structure-activity relationships were derived. Conclusions. A set of different thiazolidinone-and pyrazoline-related derivatives with antitrypanosomal and anticancer properties was screened against Plasmodium falciparum. Hitcompounds inhibiting growth of the parasite at micromolar concentrations were identified. The obtained results provide further avenues to develop more potent antimalarial agents on the base of investigated classes of small drug-like molecules.

30 June 2016 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
NZNataliya Zelisko
Nataliya Zelisko
Roman LesykRoman Lesyk
Roman Lesyk